Feature | May 30, 2013

First Large-Scale U.S. Study Validates the Benefits of 3-D Mammography

Houston-based researchers document the value of 3-D mammography as a breast cancer screening technology.

May 30, 2013 — A recently published clinical study conducted at TOPS Comprehensive Breast Center in Houston, Texas, demonstrates that 3-D mammography (breast tomosynthesis) significantly reduces unnecessary recalls while simultaneously increasing cancer detection.

The study, "Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study," was led by Stephen L. Rose, M.D., and published in the June issue of the American Journal of Roentgenology (AJR). 

The study examined the use of Hologic's 3-D mammography in conjunction with 2-D mammography. The researchers found that 3-D mammography:

  • Reduced recall rates by 37 percent;
  • Increased the detection of cancers by over 30 percent; and
  • Increased the detection of invasive cancers by more than 50 percent.

 

Instead of viewing all the complexities of the breast tissue in a flat image as with a traditional mammogram, 3-D mammography uses multiple low-dose images to create a 3-D view of the breast. 3-D mammography allows the doctor to examine 3-D breast images layer-by-layer.

The 2010 through 2012 study population included 13,856 women who received conventional 2-D mammography screening exams prior to the introduction of Hologic's 3-D mammography technology (breast tomosynthesis) and 9,499 women who received a 3-D mammography screening exam. Images in both time periods were interpreted by six radiologists with an average 12 years of reading experience.  

"We are finding cancerous breast tumors as small as two to three millimeters," Rose said. "We are finding cancer earlier and this will allow us to reduce the amount of treatment patients need."  Rose projects that as 3-D mammography becomes the standard breast cancer screening tool the size of tumors found will get smaller, and accuracy of deciding between benign and cancerous tumors will improve.

    For more information: www.breasttomo.com

 

Related Content

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Feature | Breast Density | July 05, 2017 | By Nancy M. Cappello, Ph.D.
Two decades of research on the masking risk of dense breast tissue by mammography screening is indisputable. As the...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
GE Healthcare Announces First U.S. Installation of Senographe Pristina Mammography System
News | Mammography | June 29, 2017
GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable...
Overlay Init